Trial Profile
Use of the Cannabinoid Nabilone for the Promotion of Sleep in Chronic, Non-Malignant Pain Patients: A Placebo-Controlled, Randomized, Crossover Insomnia Pilot Study
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 15 May 2019
Price :
$35
*
At a glance
- Drugs Nabilone (Primary)
- Indications Insomnia; Pain
- Focus Therapeutic Use
- 13 Jul 2018 According to a Bausch Health Companies media release, Valeant Pharmaceuticals International changed its name to Bausch Health Companies.
- 24 Jun 2014 New trial record